Dulari Jayawardena Selected Research

Proteins (Proteins, Gene)

2/2024	Ion Transport Basis of Diarrhea, Paneth Cell Metaplasia, and Upregulation of Mechanosensory Pathway in Anti-CD40 Colitis Mice.
1/2021	A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.
1/2021	Cryptosporidium parvum infection induces autophagy in intestinal epithelial cells.
3/2020	Citrobacter rodentium Infection Inhibits Colonic P-glycoprotein Expression.
12/2019	Decreased SLC26A3 expression and function in intestinal epithelial cells in response to Cryptosporidium parvum infection.
1/2018	Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins.
11/2017	Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.
1/2017	GLP-1 nanomedicine alleviates gut inflammation.
1/2016	Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dulari Jayawardena Research Topics

Disease

8	Inflammation (Inflammations) 05/2024 - 01/2017
6	Adenoma (Adenomas) 02/2024 - 01/2017
4	Colitis 02/2024 - 01/2017
4	Infections 01/2021 - 01/2018
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2017
4	Diarrhea 12/2019 - 01/2017
3	Dysbiosis 05/2024 - 01/2021
2	Ulcerative Colitis 01/2023 - 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024
1	Metaplasia 02/2024
1	Crohn Disease (Crohn's Disease) 01/2020
1	Hypotension (Low Blood Pressure) 11/2017
1	Rheumatoid Arthritis 11/2017
1	Immune System Diseases (Immune Disorders) 11/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2017
1	Fibrosis (Cirrhosis) 01/2016
1	Neoplasms (Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2016
4	CytokinesIBA 05/2024 - 01/2017
4	ChloridesIBA 01/2023 - 01/2017
4	Messenger RNA (mRNA)IBA 03/2020 - 11/2017
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2024 - 03/2020
2	Cadherins (E-Cadherin)IBA 02/2024 - 01/2018
2	Volatile Fatty AcidsIBA 01/2021 - 01/2020
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 01/2017
2	Dextrans (Dextran)FDA Link 01/2020 - 01/2017
2	Chloride-Bicarbonate AntiportersIBA 12/2019 - 11/2017
2	Peptides (Polypeptides)IBA 11/2017 - 07/2017
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 11/2017 - 07/2017
1	Butyrates (Butyrate)IBA 05/2024
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 04/2024
1	XenobioticsIBA 02/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2024
1	Claudin-2IBA 02/2024
1	Hematoxylin (Haematoxylon)IBA 02/2024
1	Tight Junction ProteinsIBA 01/2021
1	Dietary Fiber FDA Link 01/2021
1	AnionsIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	AcidsIBA 01/2020
1	MicronutrientsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 12/2019
1	fluorescein isothiocyanate dextranIBA 01/2018
1	Claudin-4IBA 01/2018
1	OccludinIBA 01/2018
1	Therapeutic UsesIBA 11/2017
1	Hormones (Hormone)IBA 11/2017
1	Dextran SulfateIBA 11/2017
1	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 07/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	GalactosamineIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Asialoglycoprotein ReceptorIBA 01/2016
1	LigandsIBA 01/2016
1	Connective Tissue Growth FactorIBA 01/2016

Therapy/Procedure

1	Therapeutics 01/2019
1	RNAi Therapeutics 01/2016